184 related articles for article (PubMed ID: 21691803)
21. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
Arafa MH; Atteia HH
Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetic analysis of tramadol and
Lee J; Yoo HD; Bae JW; Lee S; Shin KH
Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765
[No Abstract] [Full Text] [Related]
23. Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants.
Allegaert K; van Schaik RH; Vermeersch S; Verbesselt R; Cossey V; Vanhole C; van Fessem M; de Hoon J; van den Anker JN
Pediatr Res; 2008 Jun; 63(6):674-9. PubMed ID: 18317231
[TBL] [Abstract][Full Text] [Related]
24. Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns.
Wendt FR; Novroski NMM; Rahikainen AL; Sajantila A; Budowle B
Am J Forensic Med Pathol; 2019 Mar; 40(1):8-18. PubMed ID: 30507617
[TBL] [Abstract][Full Text] [Related]
25. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
[TBL] [Abstract][Full Text] [Related]
26. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
Borlak J; Hermann R; Erb K; Thum T
Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
[TBL] [Abstract][Full Text] [Related]
27. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
[TBL] [Abstract][Full Text] [Related]
28. Fatal intoxication due to tramadol alone: case report and review of the literature.
De Decker K; Cordonnier J; Jacobs W; Coucke V; Schepens P; Jorens PG
Forensic Sci Int; 2008 Feb; 175(1):79-82. PubMed ID: 17875377
[TBL] [Abstract][Full Text] [Related]
29. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
30. The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status.
Fliegert F; Kurth B; Göhler K
Eur J Clin Pharmacol; 2005 Jun; 61(4):257-66. PubMed ID: 15906019
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF
Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
[TBL] [Abstract][Full Text] [Related]
32. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
[TBL] [Abstract][Full Text] [Related]
33. Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.
Abdel-Rahman SM; Leeder JS; Wilson JT; Gaedigk A; Gotschall RR; Medve R; Liao S; Spielberg SP; Kearns GL
J Clin Pharmacol; 2002 Jan; 42(1):24-9. PubMed ID: 11808821
[TBL] [Abstract][Full Text] [Related]
34. Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
Saarikoski T; Saari TI; Hagelberg NM; Neuvonen M; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
Eur J Clin Pharmacol; 2013 Jun; 69(6):1293-301. PubMed ID: 23242004
[TBL] [Abstract][Full Text] [Related]
35. Basic pharmacology relevant to drug abuse assessment: tramadol as example.
Raffa RB
J Clin Pharm Ther; 2008 Apr; 33(2):101-8. PubMed ID: 18315774
[TBL] [Abstract][Full Text] [Related]
36. Tissue distribution of tramadol and metabolites in an overdose fatality.
Moore KA; Cina SJ; Jones R; Selby DM; Levine B; Smith ML
Am J Forensic Med Pathol; 1999 Mar; 20(1):98-100. PubMed ID: 10208348
[TBL] [Abstract][Full Text] [Related]
37. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
[TBL] [Abstract][Full Text] [Related]
38. The hypoalgesic effect of tramadol in relation to CYP2D6.
Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
[TBL] [Abstract][Full Text] [Related]
39. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response.
Slanar O; Nobilis M; Kvetina J; Idle JR; Perlík F
Eur J Clin Pharmacol; 2006 Jan; 62(1):75-6; author reply 77-8. PubMed ID: 16283276
[No Abstract] [Full Text] [Related]
40. Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.
Pedersen RS; Damkier P; Brøsen K
Eur J Clin Pharmacol; 2006 Jul; 62(7):513-21. PubMed ID: 16763825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]